|Articles|March 5, 2013

Biova Raises Egg Membrane Protein Level to 88%

The joint-health ingredient is produced using the company’s patented Hydro5 technology.

Biova LLC (Johnston, IA) has increased the standardized protein composition of its BiovaFlex water-soluble egg membrane ingredient to what it calls a market-leading 88%. The joint-health ingredient is produced using the company’s patented Hydro5 technology.

“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” says Matt Stegenga, Biova’s director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine, and transforming growth factor. So, yes, hitting uniform 88% protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”

Newsletter

From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.